Table 4

 Number (%) of patients reporting adverse events within various organ systems during the study

Azithromycin (n = 81)Placebo (n = 71)p Value*
2 Test.
Gastrointestinal30 (37)12 (17)0.006
Fungal infections2 (2)1 (1)0.64
Respiratory10 (12)9 (13)0.95
Cutaneous5 (6)3 (4)0.59
Stomatitis2 (2)1 (1)0.64
Neurological2 (2)1 (1)0.64
Headache3 (4)00.10
Urogenital1 (1)2 (3)0.48
Laboratory abnormalities1 (1)3 (4)0.25
Miscellaneous13 (16)10 (14)0.60